Have a series of complex patients reviewed, analyzed, and then offered a management plan from Watson vs. several cancer experts, then judge which recommendations are more helpful to physicians and patients (based on perceived value by the recipients of those recommendations or, ideally, by treatment outcome).
FORBES: Is IBM's Watson in Jeopardy? This Oncologist Thinks So!